Letter | Published:

CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs

Nature volume 440, pages 540544 (23 March 2006) | Download Citation



Naive lymphocytes continually enter and exit lymphoid organs in a recirculation process that is essential for immune surveillance. During immune responses, the egress process can be shut down transiently1. When this occurs locally it increases lymphocyte numbers in the responding lymphoid organ; when it occurs systemically it can lead to immunosuppression as a result of the depletion of recirculating lymphocytes. Several mediators of the innate immune system are known to cause shutdown, including interferon α/β (IFN-α/β) and tumour necrosis factor2,3,4,5, but the mechanism has been unclear. Here we show that treatment with the IFN-α/β inducer polyinosine polycytidylic acid (hereafter ‘poly(I:C)’) inhibited egress by a mechanism that was partly lymphocyte-intrinsic. The transmembrane C-type lectin CD69 was rapidly induced and CD69-/- cells were poorly retained in lymphoid tissues after treatment with poly(I:C) or infection with lymphocytic choriomeningitis virus. Lymphocyte egress requires sphingosine 1-phosphate receptor-1 (S1P1), and IFN-α/β was found to inhibit lymphocyte responsiveness to S1P. By contrast, CD69-/- cells retained S1P1 function after exposure to IFN-α/β. In coexpression experiments, CD69 inhibited S1P1 chemotactic function and led to downmodulation of S1P1. In a reporter assay, S1P1 crosslinking led to co-crosslinking and activation of a CD69–CD3ζ chimaera. CD69 co-immunoprecipitated with S1P1 but not the related receptor, S1P3. These observations indicate that CD69 forms a complex with and negatively regulates S1P1 and that it functions downstream of IFN-α/β, and possibly other activating stimuli, to promote lymphocyte retention in lymphoid organs.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    & The immediate effect of antigens on the cell output of a lymph node. Br. J. Exp. Pathol. 46, 450–454 (1965)

  2. 2.

    Influence of polyinosinic:polycytidylic acid on the circulating white blood cells in mice. Proc. Soc. Exp. Biol. Med. 142, 1087–1091 (1973)

  3. 3.

    , & Effect of interferon on thoracic duct lymphocyte output: induction with either poly I:poly C or vaccinia virus. J. Immunol. 130, 2236–2240 (1983)

  4. 4.

    , , & Recombinant bovine interferon-alpha I 1 inhibits the migration of lymphocytes from lymph nodes but not into lymph nodes. Reg. Immunol. 1, 56–61 (1988)

  5. 5.

    , , , & A role for lymphatic endothelium in the sequestration of recirculating gamma delta T cells in TNF-alpha-stimulated lymph nodes. Eur. J. Immunol. 30, 327–334 (2000)

  6. 6.

    et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427, 355–360 (2004)

  7. 7.

    , , & Expression of the sphingosine-1-phosphate receptor, S1P1, on T-cells controls thymic emigration. J. Biol. Chem. 279, 15396–15401 (2004)

  8. 8.

    et al. A potential role for CD69 in thymocyte emigration. Int. Immunol. 14, 535–544 (2002)

  9. 9.

    et al. The generation of mature, single-positive thymocytes in vivo is dysregulated by CD69 blockade or overexpression. J. Immunol. 168, 87–94 (2002)

  10. 10.

    et al. Phenotypic and functional characteristics of hematopoietic cell lineages in CD69-deficient mice. Blood 95, 2312–2320 (2000)

  11. 11.

    et al. CD69-null mice protected from arthritis induced with anti-type II collagen antibodies. Int. Immunol. 15, 987–992 (2003)

  12. 12.

    , , & The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunol. Today 15, 479–483 (1994)

  13. 13.

    , & CD69 is an immunoregulatory molecule induced following activation. Trends Immunol. 26, 136–140 (2005)

  14. 14.

    et al. CD69 in resting and activated T lymphocytes. Its association with a GTP binding protein and biochemical requirements for its expression. J. Immunol. 146, 4105–4114 (1991)

  15. 15.

    et al. Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone. Nature Immunol. 5, 713–720 (2004)

  16. 16.

    et al. Systematic identification of regulatory proteins critical for T-cell activation. J. Biol. 2, 21.1–21.16 (2003)

  17. 17.

    , & FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am. J. Transplant. 4, 1019–1025 (2004)

  18. 18.

    , , & Rapid induction of medullary thymocyte phenotypic maturation and egress inhibition by nanomolar sphingosine 1-phosphate receptor agonist. Proc. Natl Acad. Sci. USA 100, 10907–10912 (2003)

  19. 19.

    et al. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 309, 1735–1739 (2005)

  20. 20.

    , , , & Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296, 1323–1326 (2002)

  21. 21.

    et al. Transcriptional regulation of the gene encoding the human C-type lectin leukocyte receptor AIM/CD69 and functional characterization of its tumor necrosis factor-alpha-responsive elements. J. Biol. Chem. 270, 21545–21551 (1995)

  22. 22.

    & Activation-regulated expression and chemotactic function of sphingosine 1-phosphate receptors in mouse splenic T cells. FASEB J. 16, 1874–1878 (2002)

  23. 23.

    et al. Enhanced antitumor immunity in mice deficient in CD69. J. Exp. Med. 197, 1093–1106 (2003)

  24. 24.

    , , , & Pertussis toxin inhibits activation-induced cell death of human thymocytes, pre-B leukemia cells and monocytes. J. Exp. Med. 180, 1147–1152 (1994)

  25. 25.

    et al. Functional analysis of ligand-binding and signal transduction domains of CD69 and CD23 C-type lectin leukocyte receptors. J. Immunol. 165, 3868–3875 (2000)

  26. 26.

    , , & Regulating T helper cell immunity through antigen responsiveness and calcium entry. Nature Immunol. 1, 402–412 (2000)

  27. 27.

    & Sphingosine 1-phosphate pathway therapeutics: a lipid ligand-receptor paradigm. Curr. Opin. Chem. Biol. 7, 461–468 (2003)

  28. 28.

    et al. Functional role of type I and type II interferons in antiviral defense. Science 264, 1918–1921 (1994)

  29. 29.

    , , & Cyclical modulation of sphingosine-1-phosphate receptor 1 surface expression during lymphocyte recirculation and relationship to lymphoid organ transit. J. Exp. Med. 201, 291–301 (2005)

  30. 30.

    et al. Cutting edge: Lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor. J. Immunol. 175, 7796–7799 (2005)

Download references


We thank T. Nakayama and S. Zeigler for CD69-/- mice; K. Murali-Krishna for Ifnar1-/- mice; R. Proia for S1p1+/- mice; S. Jahn for technical assistance; C. Allen, S. Schwab and C. McArthur for help with cell sorting; K. Kabashima for fetal liver chimeras; O. Lam for mouse husbandry; and S. Schwab and C. Lo for comments on the manuscript. L.R.S. is supported by the UCSF Medical Scientist Training Program; D.B.R. is supported by the Genentech Graduate Fellowship; M.M. was supported by the Pfizer Postdoctoral Fellowship in Immunology and Rheumatology, a research award from the Arthritis Foundation, the Rosalind Russell Medical Research Center for Arthritis at UCSF, and the Sandler Family Supporting Foundation; L.L.L. is an American Cancer Society Research Professor; J.G.C. is an Investigator of the Howard Hughes Medical Institute. This work was supported in part by grants from the NIH (to L.L.L. and J.G.C.).

Author information


  1. Howard Hughes Medical Institute,

    • Lawrence R. Shiow
    • , Ying Xu
    • , Jinping An
    •  & Jason G. Cyster
  2. Department of Microbiology and Immunology,

    • Lawrence R. Shiow
    • , David B. Rosen
    • , Ying Xu
    • , Jinping An
    • , Lewis L. Lanier
    •  & Jason G. Cyster
  3. Department of Medicine, and

    • Naděžda Brdičková
    •  & Mehrdad Matloubian
  4. Biomedical Sciences Graduate Program, University of California, San Francisco, San Francisco, California 94143, USA

    • Lawrence R. Shiow
    •  & David B. Rosen


  1. Search for Lawrence R. Shiow in:

  2. Search for David B. Rosen in:

  3. Search for Naděžda Brdičková in:

  4. Search for Ying Xu in:

  5. Search for Jinping An in:

  6. Search for Lewis L. Lanier in:

  7. Search for Jason G. Cyster in:

  8. Search for Mehrdad Matloubian in:

Competing interests

Reprints and permissions information is available at npg.nature.com/reprintsandpermissions. The authors declare no competing financial interests.

Corresponding authors

Correspondence to Jason G. Cyster or Mehrdad Matloubian.

Supplementary information

PDF files

  1. 1.

    Supplementary Notes

    This file contains Supplementary Figures 1–4 with corresponding legends, Supplementary Methods and additional references.

About this article

Publication history






Further reading Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.